未登录

T

Tianfang Jiang

Shanghai Municipal Eighth People's Hospital

H指数:10

被引数:1,217

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Changes in gut microbiota and plasma metabolites in Parkinson’s disease patients with pain as analyzed by 16S rDNA sequencing and LC-MS

通过16S rDNA测序和LC-MS分析疼痛型帕金森病患者肠道微生物群和血浆代谢物的变化

IF2.6

2025-09-120

PRE

Can pluripotent/multipotent stem cells reverse Parkinson's disease progression?

FRONTIERS IN NEUROSCIENCE

IF3.2

2024-01-312

OAAI

Cathepsin L-containing exosomes from α-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor

NPJ PARKINSONS DISEASE

IF8.2

2022-10-0612

OAAI

Rebuilding hippocampus neural circuit with hADSC-derived neuron cells for treating ischemic stroke

CELL AND BIOSCIENCE

IF6.2

2022-04-043

OAAI

The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit? (vol 9, 2047, 2018)

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-10-160

OAAI

The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?

FRONTIERS IN IMMUNOLOGY

IF5.9

2018-09-2741

OAAI

Clinical Profile of Chinese Long-Term Parkinson's Disease Survivors With 10 Years of Disease Duration and Beyond

病程10年及以上的中国帕金森病长期存活者的临床特征

AGING AND DISEASE

IF6.9

2018-01-0120

OAAI

DJ-1 Inhibits α-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2017-09-27110

OAAI

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease

PROGRESS IN NEUROBIOLOGY

IF6.1

2016-12-01505

PREAI

Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients

富亮氨酸重复激酶2变异体对帕金森病患者运动和非运动症状的影响

AGING AND DISEASE

IF6.9

2016-01-0117

OAAI

P2X7 receptor is critical in α-synuclein-mediated microglial NADPH oxidase activation

NEUROBIOLOGY OF AGING

IF3.5

2015-07-0197

PREAI

Curcumin Ameliorates the Neurodegenerative Pathology in A53T α-synuclein Cell Model of Parkinson's Disease Through the Downregulation of mTOR/p70S6K Signaling and the Recovery of Macroautophagy

JOURNAL OF NEUROIMMUNE PHARMACOLOGY

IF3.5

2013-01-17185

PREAI

Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson's disease: potential therapeutic targets?

帕金森病 α-突触核蛋白两种溶酶体降解途径的功能障碍: 潜在的治疗靶点？

NEUROSCIENCE BULLETIN

IF5.8

2012-09-0815

OA